Backwards about moving forwards

Clinical trials have long been famous for their sophistication and lengthy timespans. But traditionally, organisers have paid less attention to what happens once the research is done and medications have to be disposed of. Yet, with so-called reverse logistics offering a range of financial and other efficiencies, this is changing fast. Andrea Valentino talks to Kimberly Finn at Marken and Edward Groleau at PCI Pharma Services to learn more.